Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s133. https://doi.org/10.25251/skin.7.supp.133